Fractyl Health, Inc. GUTS
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.28M | 5.22M | 6.79M | 5.24M | 4.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.10M | 20.82M | 23.28M | 22.69M | 26.08M |
| Operating Income | -19.10M | -20.82M | -23.28M | -22.69M | -26.08M |
| Income Before Tax | -25.54M | 9.22M | -43.73M | -45.60M | -27.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.54M | 9.22M | -43.73M | -45.60M | -27.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.54M | 9.22M | -43.73M | -45.60M | -27.89M |
| EBIT | -19.10M | -20.82M | -23.28M | -22.69M | -26.08M |
| EBITDA | -18.82M | -20.54M | -23.01M | -22.40M | -25.81M |
| EPS Basic | -1.93 | 0.70 | -3.73 | -8.46 | -6.82 |
| Normalized Basic EPS | -1.14 | 0.47 | -2.29 | -5.07 | -4.01 |
| EPS Diluted | -1.93 | 0.70 | -3.73 | -8.46 | -6.82 |
| Normalized Diluted EPS | -1.14 | 0.47 | -2.29 | -5.07 | -4.01 |
| Average Basic Shares Outstanding | 13.22M | 13.21M | 11.71M | 5.39M | 4.09M |
| Average Diluted Shares Outstanding | 13.22M | 13.21M | 11.71M | 5.39M | 4.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |